STIM
Neuronetics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$83.50M
P/E Ratio
—
EPS
$-0.54
Beta
1.13
52W High
$4.85
52W Low
$0.80
50-Day MA
$1.50
200-Day MA
$2.06
Dividend Yield
—
Profit Margin
-24.50%
Forward P/E
—
PEG Ratio
—
About Neuronetics Inc
Neuronetics, Inc., a commercial-stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company is headquartered in Malvern, Pennsylvania.
Fundamentals
| Revenue (TTM) | $151.64M |
| Gross Profit (TTM) | $73.12M |
| EBITDA | $-25.78M |
| Operating Margin | -26.10% |
| Return on Equity | -131.60% |
| Return on Assets | -13.60% |
| Revenue/Share (TTM) | $2.23 |
| Book Value | $0.19 |
| Price-to-Book | 6.30 |
| Price-to-Sales (TTM) | 0.55 |
| EV/Revenue | 1.025 |
| EV/EBITDA | -2.02 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 7.80% |
| Shares Outstanding | $69.59M |
| Float | $30.46M |
| % Insiders | 32.19% |
| % Institutions | 59.86% |
Historical Volatility
HV 10-Day
155.99%
HV 20-Day
139.59%
HV 30-Day
123.70%
HV 60-Day
117.55%
HV Rank
94.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($4.33 target)
2
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026